← Back to Search

Behavioral Intervention

iACT for Type 1 Diabetes with Eating Disorders

N/A
Recruiting
Led By Rhonda Merwin, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Type 1 diabetes
16-50 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 39 months from start of enrollment
Awards & highlights

Study Summary

This trial tests an mHealth intervention to help people with type 1 diabetes and eating disorders better manage their health and diabetes. Outcomes include glycemic control, eating disorder symptoms and diabetes distress.

Who is the study for?
This trial is for people aged 16-50 with Type 1 Diabetes who also struggle with eating disorders like bulimia or binge eating. They must manage their diabetes independently and not have a history of substance abuse, psychosis, suicidal behavior, certain other eating disorders, or be non-English speakers.Check my eligibility
What is being tested?
The study tests iACT, a mobile health intervention against usual care to see which helps better with glycemic control in Type 1 Diabetics with eating disorders. Participants will be randomly assigned to one of the two groups and monitored over nine months.See study design
What are the potential side effects?
Since iACT is a behavioral intervention using mobile technology rather than medication, it may not have typical drug side effects but could include emotional distress or discomfort from confronting disordered eating behaviors.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Type 1 diabetes.
Select...
I am between 16 and 50 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~39 months from start of enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 39 months from start of enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability as measured by meeting the recruitment target for the study
Change in diabetes self-management as indexed by the Diabetes Self-Management Questionnaire
Change in eating disorder symptoms as indexed by the Diabetes Eating Problems Survey
+4 more
Secondary outcome measures
Change in NIH PROMIS Scale - Anxiety
Change in NIH PROMIS Scale - Depression
Change in diabetes distress as indexed by the Type 1 - Diabetes Distress Scale

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: iACT Experimental InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,356 Previous Clinical Trials
3,408,973 Total Patients Enrolled
The Miriam HospitalOTHER
238 Previous Clinical Trials
37,477 Total Patients Enrolled
Rhonda Merwin, PhDPrincipal InvestigatorDuke University faculty
4 Previous Clinical Trials
185 Total Patients Enrolled

Media Library

iACT (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05540704 — N/A
Type 1 Diabetes Research Study Groups: iACT Experimental Intervention, Usual Care
Type 1 Diabetes Clinical Trial 2023: iACT Highlights & Side Effects. Trial Name: NCT05540704 — N/A
iACT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05540704 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

May I partake in this clinical experiment?

"To be eligible for this diabetes trial, volunteers must have type 1 diabetes and a chronological age between 16 and 50. A total of 128 individuals are needed to participate in the study."

Answered by AI

Is this trial actively seeking volunteers?

"This clinical trial, which was initially publicized on April 4th 2023 and updated recently on the 18th of the same month, is currently in search for participants. The information can be found through clinicaltrials.gov."

Answered by AI

Does this research permit individuals of forty years and older to participate?

"According to the stipulations of this clinical trial, participants must be aged between 16 and 50 years old. For those younger than 16 or older than 65, 263 and 991 trials respectively are available for their consideration."

Answered by AI

How many participants have taken part in this experiment thus far?

"Affirmative. Clinicaltrials.gov indicates that this clinical trial is recruiting participants at the moment, first being posted on April 4th 2023 and last updated 18 days later. It requires 128 patients to be enrolled between two medical sites."

Answered by AI
~85 spots leftby Jun 2026